Understanding Drug Synergy in Pancreatic Cancer: A Proteomic Study of Gemcitabine and ATR Inhibitors
Year: 2024
Type: dissertation
Abstract: This study employed (phospho-)proteomics to explain the molecular mechanism behind the drug synergy between Gemcitabine and ATR kinase inhibitors in pancreatic cancer. The insights gained from this work could guide future clinical strategies for cancer treatment.
Authors: Höfer, Stefanie I., Küster, Bernhard 1967-, Technische Universität München
Language: German
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7025329054